|Articles|May 20, 2021
Use of a MAbPac RP capillary column to monitor glycosylation site occupancy in therapeutics
Author(s)Thermo Fisher Scientific
A new approach using the novel, easy-to-connect Thermo Scientific MAbPac RP capillary column for determining glycosylation site occupancy of therapeutic antibodies from the analysis of their tryptic digest.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
AdvanCell Targets GI Cancer With Peptide-Driven Lead-212 Radiotherapy
3
Genentech Expands RNAi Pipeline Through Global Licensing Deal
4
Pfizer Phase IIb Data Support Monthly GLP-1 Dosing for Obesity
5